Financial anchor year: FY24. Margin and revenue are as filed for FY24. Balance-sheet measures (current ratio, equity financing, days in A/R) use FY22, the latest filing whose balance sheet reconciled as filed. Every tile below states its own fiscal year; nothing is carried forward or estimated.
The read
A dialysis facility in Pampa, TX. It ran an operating surplus of 31.4% in FY24 on $2.8M of operating revenue. Operating margin improved from 15.4% in FY20 to 31.4% in FY24, though it fell 1.0 points in the most recent year.
Operating margin · FY24
+31.4%
▼ 1.0 pts vs FY23
vs dialysis facilities90th pctl of 7,741
Days cash on hand
Not available
vs dialysis facilities—
Total operating revenue · FY24
$2.8M
▼ 0.2 $M vs FY23
vs dialysis facilities44th pctl
Total margin · incl. nonoperating · FY24
+31.4%
▼ 1.0 pts vs FY23
vs dialysis facilities92nd pctl
Where FRESENIUS MEDICAL CARE sits among dialysis facilities
Operating margin · FY24 pool · n = 7,741 of 7,741 filed
Each point is one dialysis facility in the national distribution for this provider type, placed by operating margin. Facilities are not matched on size, case mix, or market — that is the matched-peer comparison in the paid benchmark. The dialysis facility median is +11.9%. Descriptive context only, not a ranking.
One dialysis facilityFRESENIUS MEDICALdialysis facility median
The money
$ thousands · HCRIS cost-report basis · as filed, QA-gated
Ratios tell you how this dialysis facility is doing. Statements tell you what kind of organization it is, and where the money comes from. Every figure below traces to a public cost-report filing, shown as filed. A ratio renders only when every input is reported in the filing; a year missing its core lines is not shown; a year whose balance sheet does not reconcile is labeled. Not audited by Astrelis.
Operating margin
+31.4% (FY24)
Operating income ÷ total operating revenue
HCRIS WS G-3
Total margin
+31.4% (FY24)
Net income ÷ total revenue incl. nonoperating
HCRIS WS G-3
Days cash on hand
Not reported in this filing
Cash & investments ÷ daily operating expense
HCRIS WS G / G-3
Current ratio
0.93× (FY22)
Total current assets ÷ current liabilities
HCRIS WS G
Equity financing ratio
Not reported in this filing
Total net assets ÷ total assets
HCRIS WS G
Days in net patient A/R
Not reported in this filing
Net patient receivables ÷ (net patient revenue ÷ 365), same fiscal year
HCRIS WS G / G-3
$ in thousands
Line item
FY22
FY23
FY24
Patient revenue
2,430
2,979
2,769
Total operating revenue
2,430
2,979
2,769
Total operating expenses
1,890
2,013
1,901
Operating income
540
966
868
Operating margin %
+22.2%
+32.4%
+31.3%
Other non-operating, net
0
0
0
Net income
540
966
868
Net income %
+22.2%
+32.4%
+31.3%
HCRIS CMS-265 cost report · $ thousands · FY20–FY24 · operating revenue reflects net patient service revenue · FY20–21 may include COVID-era relief funding
A condensed balance sheet is not shown for this dialysis facility: the public cost report does not carry substantive balance-sheet detail (assets, liabilities, and net assets that reconcile) for this provider. The income statement and ratio exhibit above are the reliable financial view here. We lead with those rather than render a hollow table.
How it operates
quality & operational context · CMS public reporting
The metrics this dialysis facility type is judged on: care quality, patient experience, and scale. Each is labeled by evidence class and public source; descriptive context only, never a ranking or adequacy claim.
Economic context: 12.7% of county personal income is Medicare/Medicaid medical benefits; 26.1% arrives as government transfers (BEA, 2022).
The Board Briefing$1,000
The free profile shows the record. The Board Briefing tells you what changed, what matters, and what your board should ask. 35+ pages, built entirely from public sources, no client data required. Delivered within 2 business days. If we cannot deliver the published scope for your facility, you pay nothing.
